Therapy Areas: Central Nervous System
7 July 2020 - Molecular diagnostic company Asuragen Inc on Tuesday reported the receipt of the CE Mark for the AmplideX SMA Plus Kit vitro diagnostic assay to aid in the diagnosis of spinal muscular a...
1 July 2020 - Neuro-Sys, a company that deals with pharmacological Contract Research Services specialising in the R&D and in vitro testing of molecules used to treat neurogenerative diseases in th...
24 June 2020 - - One additional Phase 3 trial, along with previously completed Phase 2 trial, would be acceptable to support an efficacy claim for a New Drug Application filing
company on track ...
12 June 2020 - - The US Food and Drug Administration has granted Orphan Drug Designation for US-based biopharmaceutical company CNS Pharmaceuticals, Inc's (NASDAQ: CNSP) lead product Berubicin fo...
12 June 2020 - The US Food and Drug Administration (FDA) said on Thursday that it has granted approval for Viela Bio's (NASDAQ:VIE) Uplizna (inebilizumab-cdon) injection for the treatment of neur...
3 June 2020 - - The US Food and Drug Administration has given Canada-based FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) permission to submit an Investigational New Drug Application for th...